Differential expression analysis of all timepoints indicate that hundreds of genes have their transcriptional profile changed as a response to anti-EGFR therapy in all three HNSCC cell lines with changes occurring as early as 24 h after treatment (Supplementary Fig. 3A, Supplementary Tables 2–5). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.